ArticleBMJ global health2026
Building a National Infection Prevention and Control Programme: the 'Turn Nigeria Orange' Programme, 2019-2023.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strong infection prevention and control (IPC) programmes are critical to reducing the burden of healthcare-associated infections and antimicrobial resistance (AMR), yet many low- and middle-income countries (LMICs) lack functional IPC programmes at national and health facility levels. Nigeria prioritised the development of a national programme to provide leadership and coordination for IPC activities throughout the country's healthcare system following a series of outbreaks and gaps identified during the development of the National Action Plan for AMR. We aim to describe the stepwise, evidence-based approach we used to establish and implement Nigeria's National IPC Programme during its first 5 years. This includes the formation and structure of the IPC Programme within the Nigeria Centre for Disease Control and Prevention; assessment of national and tertiary health facility-level IPC programmes to prioritise interventions; development of a structured implementation strategy (the 'Turn Nigeria Orange' programme); publication of national IPC guidelines and revision of the national IPC policy; collaboration with a local university and professional societies to establish a national IPC curriculum and IPC training and mentorship programmes; and establishment of a network of health facilities to strengthen facility-level implementation (the 'Orange Network'). The development of each was guided by the WHO's core components of IPC programmes, evidence-based guidelines which aim to inform the development of effective IPC programmes. The implementation approaches, successes and challenges that we share add to the limited existing literature and can serve as a practical example for other countries, particularly LMICs when establishing and implementing IPC programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.